Antipruritic and antihyperalgesic actions of loperamide and analogs

  • De Haven-Hudkins D
  • Cowan A
  • Cortes Burgos L
 et al. 
  • 5


    Mendeley users who have this article in their library.
  • 22


    Citations of this article.


Loperamide and three of its analogs were evaluated for their ability to inhibit binding to cloned human opioid receptor subtypes and to produce antipruritis and antinociception following local s.c. administration to rodents. All four compounds were fully efficacious agonists with affinities of 2 to 4 nM for the cloned human μ opioid receptor. Local s.c. injection of loperamide, ADL 01-0001 or ADL 01-0002 at the same site as the introduction of the pruritogenic compound 48/80 resulted in antipruritic activity in a mouse model of itch. Similarly, i.paw or administration of compounds ADL 01-0001, ADL 01-0002 and ADL 01-0003 to inflamed paws caused potent antinociception, inhibiting late phase formalin-induced flinching, Freund's adjuvant-induced mechanical hyperalgesia and tape stripping-induced mechanical hyperalgesia. Loperamide and its analogs were efficacious in animal models of itch and inflammatory pain, and may have potential therapeutic utility as antipruritic and antihyperalgesic agents. © 2002 Elsevier Science Inc. All rights reserved.

Author-supplied keywords

  • 1-piperidinebutyramides
  • Antinociception
  • Antipruritis
  • Loperamide
  • Loperamide analogs
  • Peripheral selectivity

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Diane L. De Haven-Hudkins

  • Luz Cortes Burgos

  • Jeffrey D. Daubert

  • Joel A. Cassel

  • Robert N. DeHaven

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free